If the team behind “The Circus in Winter” has its way (and if enough money can be raised and script kinks worked out), the Ball State University-incubated musical might be the first Tony award winner conceived as a collaborative class project.
Senate Republicans unveiled a proposal Monday to allow the Indiana State Board of Education to choose its own leader, but not until Superintendent of Public Instruction Glenda Ritz, a Democrat, completes her first term in office.
ITT Educational Services Inc. was unable to get a federal judge to dismiss a predatory-lending lawsuit filed by the Consumer Financial Protection Bureau, so now it is taking its request to an appeals court.
Indiana legislative leaders are considering steps to broaden the Republican-backed proposal aimed at allowing the state Board of Education to replace the state superintendent of public instruction—currently Democrat Glenda Ritz—as its leader.
Some senators had pushed a bill calling for replacement of the exam with an "off-the-shelf" test in hopes of saving millions of dollars. But House members favored keeping ISTEP in place while undertaking a special review of a possible overhaul.
School districts across Indiana are delaying the second round of ISTEP+ testing or asking the Department of Education for permission to administer the exam with paper and pencil after experiencing continuing problems with an online server.
Indiana lawmakers were grappling Wednesday over where to make cuts in the new state budget with little more than a week remaining in the legislative session while also debating what steps should be taken to help struggling casinos.
Digital forensics students take a rigorous course load that includes criminology, policing, criminal evidence, criminal law, computer science, computer security, digital forensics and geographic information systems.
Four residents of the town of Princeton sued to revoke the university's tax exemption, in part because it shares royalties with faculty, mostly from a patent that Indianapolis-based Eli Lilly and Co. turned into the cancer drug Alimta.